Supercomputer Analyzes Lung Fluid Cells from Coronavirus Infected Patients to Repurpose Drugs for COVID-19 Treatment
Analyses of lung fluid cells from COVID-19 patients conducted on the fastest supercomputer in the US suggests that gene expression patterns may explain the runaway symptoms produced by the body’s response to SARS-CoV-2 and has led to the discovery of at least 10 existing drugs that are known to act on the specific pathways. More...03 Sep 2020
Sanofi and Regeneron Halt Further Clinical Studies for Kevzara in COVID-19 After Disappointing Phase 3 Trial Results
Sanofi S.A. (Paris, France) and Regeneron Pharmaceuticals, Inc. (Tarrytown, NY, USA) have decided to discontinue further clinical studies for Kevzara (sarilumab) in COVID-19 after suffering a setback in the drug’s Phase 3 trial. More...02 Sep 2020
NIH Sets up Centers for Research in Emerging Infectious Diseases for Rapid Responses to New Viruses Like SARS-CoV-2
The National Institutes of Health (NIH Bethesda, MA, USA) has established the Centers for Research in Emerging Infectious Diseases (CREID), a global network that will involve multi-disciplinary investigations into how and where viruses such as SARS-CoV-2 and other pathogens emerge from wildlife and spillover to cause disease in people. More...02 Sep 2020
AstraZeneca Begins Phase 3 Trial of COVID-19 Vaccine and Expands Supply Agreement with Oxford Biomedica
AstraZeneca (Cambridgeshire, England) has begun Phase 3 clinical trial of its COVID-19 vaccine candidate AZD1222 that will enroll up to 30,000 adults aged 18 years or over in the US to assess its safety, efficacy and immunogenicity. More...02 Sep 2020
New Portable, 30-Minute COVID-19 Test Could Enable Diagnosis at POC Without Need for Laboratory
Researchers have demonstrated a prototype of a rapid COVID-19 molecular test and a simple-to-use, portable instrument for reading the results with a smartphone in 30 minutes, which could enable point-of-care diagnosis without needing to send samples to a lab. More...02 Sep 2020
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
New
Transcatheter Heart Valve
SAPIEN 3 Ultra
New
Blanket Warming Cabinet
EC250
In Other News
Sinovac’s COVID-19 Vaccine Approved by China for Emergency Use to Vaccinate High-Risk Groups
GlaxoSmithKline and Vir Biotechnology Begin Phase 2/3 Study of COVID-19 Monoclonal Antibody Treatment
COVID-19 Vaccine Could Receive FDA Authorization Before Completion of Phase 3 Trials; Experts Demand Independent Data Review
Algorithm Predicts Onset of COVID-19 Symptoms from Data Collected by Wearable Smart Ring
Erba Mannheim Announces Availability of Validated Automated Protocols for ErbaLisa COVID-19 IgG and IgM ELISA Kits
Antiviral Used to Treat Coronavirus in Cats Very Likely to Be Effective Drug for COVID-19 Patients
First Confirmed US Case of Coronavirus Reinfection Raises Questions Over Efficacy of COVID-19 Vaccines
Rapid POC Antigen and Molecular COVID-19 Tests May Not Be Accurate Enough to Replace RT-PCR Tests, Finds Study
Study Confirms Efficacy of Blood Thinners as Potential Therapeutic Treatment for COVID-19
Gilead’s Remdesivir Receives Expanded FDA EUA for Treatment of All Hospitalized COVID-19 Patients
SARS-CoV-2 Serology Assay Evaluations Indicate Seropositivity Increases with Time After Symptom Onset
Thermo Fisher Opens New Plant for Manufacturing COVID-19 Sample Collection Products
Researchers Warn Against Targeting Only One Viral Gene for SARS-CoV-2 Detection by RT-PCR Due to Mutation in N Gene
Chinese COVID-19 Diagnostic Test Delivers Accurate Results in 40 Minutes Without Instrument for Less Than 70 Cents
New COVID-19 Test Shows Patients with Suppressed Immune Systems Can Also Achieve Good Immune Response to SARS-CoV-2
NIH Harnesses Power of AI and Medical Imaging for Diagnosis, Treatment and Monitoring of COVID-19
Inhaled Leukine Phase 2 Trial for COVID-19 Begins Patient Enrolment
AI-Powered COVID-19 Cough Analyzer App Assesses Respiratory Health and Associated Risks
Researchers Identify Previously Developed Drug-Like Compounds to Fight SARS That May Work Against COVID-19
New CE-Marked ELISA Test Detects COVID-19 Antibodies in Recently Infected People with Mild Symptoms
First-of-Its-Kind Mobile Testing Platform Launched to Manage and Track On-Site COVID-19 Testing
Abbott's USD 5, 15-Minute BinaxNOW COVID-19 Ag Card Becomes First Diagnostic Test with Read-Result Test Card to Receive FDA EUA
World's First Confirmed Case of COVID-19 Re-Infection Raises Questions Over Coronavirus Immunity
